Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate and Prolonged Exposure for PTSD and Alcohol Use Disorder
NCT03176953Phase 3Completed
- Sponsor
- VA Office of Research & Development
- Start
- Nov 2017
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of topiramate in alcohol use disorder (AUD), post-traumatic stress disorder (PTSD), sponsored by VA Office of Research & Development. Started Nov 2017; status: completed.
02
Drugs
topiramate
03
Conditions
alcohol use disorder (AUD)post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT03176953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03176953.